| Class | Medication | Dose | Indication | Side effects |
|---|---|---|---|---|
| Gonadotropin agonist | Human Chorionic Gonadotropin (HCG) | 1500-5000 IU 2-3x weekly Titrate up to 10K IU/week Titrate to T level |
Hypogonadotropic hypogonadism | Nausea (12%) Breast enlargement/tenderness (1-10%) Headache (34%) Injection discomfort (1-10%) |
| Human Menopausal Gonadotropin (HMG) | 75-150 IU 2-3x weekly | |||
| Selective estrogen receptor modulator | Clomiphene citrate | 25mg QD or 50mg EOD Titrate to max 100mg QD Titrate to T level |
Headache (1%) Blurred vision (2%) Flushing (10%) Breast discomfort (2%) Nausea (2%) Impaired libido Gynecomastia (rare) |
|
| Aromatase inhibitor | Anostrozole | 1mg daily | Hypergonadotropic hypogonadism (Kleinfelter syndrome) | Nausea (11-19%) Headache (9-10%) Hot flashes (12-26%) Chest discomfort (2-12%) |
| Lestrozole | 2.5mg daily | |||
| Dopamine agonist | Cabergoline | 0.25mg 2x weekly Titrate up to 1mg Titrate per prolactin levels |
Prolactin-secreting pituitary tumor | Headache (26%) Dizziness (15-17%) Nausea (27-29%) Constipation (7-10%) |
| a-agonist | Pseudoephedrine | 60mg PO QID | Retrograde ejaculation | restlessness Nausea/vomiting Weakness Headache Nervousness Dizziness Palpitations |
| Class | Procedure | Indications | Description | Side effects |
|---|---|---|---|---|
| Azoospermia diagnosis | Testis aspiration | Confirm obstructive (vs nonobstructive) azoospermia | Insert biopsy needle (thru skin or skin incision) and aspirate to assess for sperm | Hematoma, hematocele, spermatocele, hydrocele | Testis biopsy | Incise tunica albuginea, extrude tubules and remove, close incision | Low risk bleeding |
| Sperm retrieval | Tes(TESE) | Obstructive azoospermia | Obtain sperm via opening testis or epididymis and removing tubules | Bleeding, postop pain |
| microTESE | Nonobstructive azoospermia | Obtain sperm via assessing and extracting microtubules | ||
| Epididymal sperm extraction | Obstructive azoospermia with epididymal dilation | Obtain sperm via assessing and extracting microtubules | ||
| Improve sperm delivery | Vas reversal | Obstructive azoospermia (after vasectomy) | Obtain sperm via assessing and extracting microtubules | Hematoma (0.3%), granulomas (5%), delayed failure (5%), can consider TESE instead |
| Transurethral resection of ejaculatory ducts (TURED) | Obstructive azoospermia (ejaculatory ducts) | Resect ducts to remove obstruction, can transrectally inject dye to improve identification | Restenosis, pain, epididymoorchitis (chemical/infectious), retention, incontinence, hematuria | |
| Assisted reproductive technology | Intrauterine insemination (IUI) | Normal sperm but unable to reach egg naturally, oligospermia (5-8mil) | Inject collected/concentrated sperm into uterus (via cervix) to allow natural fertilization of egg | Minimal risks |
| In vitro fertilization (IVF) | Sperm unable to reach egg, oligospermia (< 5mil) | Sperm placed in proximity to egg, natural fertilization, embryos placed within uterus for implantation | Risks of egg stimulation/retrieval Multifetal pregnancy |
|
| Intracytoplasmic sperm injection (ICSI) | Sperm unable to fertilize egg, oligospermia (< 5mil) | Sperm directly injected into egg, embryos placed within uterus for implantation | Risks of egg stimulation/retrieval 4x risk for sex chromosome abnormalities Congenital malformations (slight increased risk) Spontaneous abortion/ectopic pregnancy |